Fibronectin mediates activation of stromal fibroblasts by SPARC in endometrial cancer cells

1. Nagaraju GP, Dontula R, El-Rayes BF, et al. Molecular mechanisms

underlying the divergent roles of SPARC in human carcinogenesis.

Carcinogenesis. 2014;35:967–73.

2. Wong SL, Sukkar MB. The SPARC protein: an overview of its role in lung

cancer and pulmonary fibrosis and its potential role in chronic airways

disease. Br J Pharmacol. 2017;174:3–14.

3. Robert G, Gaggioli C, Bailet O, et al. SPARC represses E-cadherin and induces

mesenchymal transition during melanoma development. Cancer Res. 2006;

66:7516–23.

4. Fenouille N, Tichet M, Dufies M, et al. The epithelial-mesenchymal transition

(EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and

AKT in promoting melanoma cell invasion. PLoS One. 2012;7:e40378.

5. Hung JY, Yen MC, Jian SF, et al. Secreted protein acidic and rich in cysteine

(SPARC) induces cell migration and epithelial mesenchymal transition

through WNK1/snail in non-small cell lung cancer. Oncotarget. 2017;8:

63691–702.

6. Brown TJ, Shaw PA, Karp X, et al. Activation of SPARC expression in reactive

stroma associated with human epithelial ovarian cancer. Gynecol Oncol.

1999;75:25–33.

7. Rodriguez-Jimenez FJ, Caldes T, Iniesta P, et al. Overexpression of SPARC

protein contrasts with its transcriptional silencing by aberrant

hypermethylation of SPARC CpG-rich region in endometrial carcinoma.

Oncol Rep. 2007;17:1301–7.

8. Sato N, Fukushima N, Maehara N, et al. SPARC/osteonectin is a frequent

target for aberrant methylation in pancreatic adenocarcinoma and a

mediator of tumor-stromal interactions. Oncogene. 2003;22:5021–30.

9. Shin M, Mizokami A, Kim J, et al. Exogenous SPARC suppresses proliferation

and migration of prostate cancer by interacting with integrin beta1.

Prostate. 2013;73:1159–70.

10. Infante JR, Matsubayashi H, Sato N, et al. Peritumoral fibroblast SPARC

expression and patient outcome with resectable pancreatic

adenocarcinoma. J Clin Oncol. 2007;25:319–25.

11. Sangaletti S, Stoppacciaro A, Guiducci C, et al. Leukocyte, rather than tumorproduced SPARC, determines stroma and collagen type IV deposition in

mammary carcinoma. J Exp Med. 2003;198:1475–85.

12. Brekken RA, Puolakkainen P, Graves DC, et al. Enhanced growth of tumors in

SPARC null mice is associated with changes in the ECM. J Clin Invest. 2003;

111:487–95.

13. Puolakkainen PA, Brekken RA, Muneer S, et al. Enhanced growth of

pancreatic tumors in SPARC-null mice is associated with decreased

deposition of extracellular matrix and reduced tumor cell apoptosis. Mol

Cancer Res. 2004;2:215–24.

Page 11 of 12

14. Sangaletti S, Di Carlo E, Gariboldi S, et al. Macrophage-derived SPARC

bridges tumor cell-extracellular matrix interactions toward metastasis.

Cancer Res. 2008;68:9050–9.

15. Arnold SA, Rivera LB, Miller AF, et al. Lack of host SPARC enhances vascular

function and tumor spread in an orthotopic murine model of pancreatic

carcinoma. Dis Model Mech. 2010;3:57–72.

16. Said N, Najwer I, Motamed K. Secreted protein acidic and rich in cysteine

(SPARC) inhibits integrin-mediated adhesion and growth factor-dependent

survival signaling in ovarian cancer. Am J Pathol. 2007;170:1054–63.

17. Said N, Frierson HF, Sanchez-Carbayo M, et al. Loss of SPARC in bladder cancer

enhances carcinogenesis and progression. J Clin Invest. 2013;123:751–66.

18. Aycock RL, Bradshaw AC, Sage EH, et al. Development of UV-induced

squamous cell carcinomas is suppressed in the absence of SPARC. J Invest

Dermatol. 2004;123:592–9.

19. Sansom OJ, Mansergh FC, Evans MJ, et al. Deficiency of SPARC suppresses

intestinal tumorigenesis in APCMin/+ mice. Gut. 2007;56:1410–4.

20. Wong SY, Crowley D, Bronson RT, et al. Analyses of the role of endogenous

SPARC in mouse models of prostate and breast cancer. Clin Exp Metastasis.

2008;25:109–18.

21. Sage EH, Reed M, Funk SE, et al. Cleavage of the matricellular protein SPARC

by matrix metalloproteinase 3 produces polypeptides that influence

angiogenesis. J Biol Chem. 2003;278:37849–57.

22. Podgorski I, Linebaugh BE, Koblinski JE, et al. Bone marrow-derived cathepsin K

cleaves SPARC in bone metastasis. Am J Pathol. 2009;175:1255–69.

23. Clark CJ, Sage EH. A prototypic matricellular protein in the tumor

microenvironment--where there's SPARC, there's fire. J Cell Biochem. 2008;

104:721–32.

24. Yusuf N, Inagaki T, Kusunoki S, et al. SPARC was overexpressed in human

endometrial cancer stem-like cells and promoted migration activity.

Gynecol Oncol. 2014;134:356–63.

25. Tomari H, Kawamura T, Asanoma K, et al. Contribution of senescence in

human endometrial stromal cells during proliferative phase to embryo

receptivity†. Biol Reprod. 2020;103:104–13.

26. Zhang N, Wang Y, Liu H, et al. Extracellular vesicle encapsulated microRNA320a inhibits endometrial cancer by suppression of the HIF1α/VEGFA axis.

Exp Cell Res. 2020;394:112113.

27. Aprelikova O, Palla J, Hibler B, et al. Silencing of miR-148a in cancerassociated fibroblasts results in WNT10B-mediated stimulation of tumor cell

motility. Oncogene. 2013;32:3246–53.

28. Aprelikova O, Yu X, Palla J, et al. The role of miR-31 and its target gene

SATB2 in cancer-associated fibroblasts. Cell Cycle. 2010;9:4387–98.

29. Subramaniam KS, Tham ST, Mohamed Z, et al. Cancer-associated fibroblasts

promote proliferation of endometrial cancer cells. PLoS One. 2013;8:e68923.

30. Teng F, Tian WY, Wang YM, et al. Cancer-associated fibroblasts promote the

progression of endometrial cancer via the SDF-1/CXCR4 axis. J Hematol

Oncol. 2016;9:8.

31. Ohmaru-Nakanishi T, Asanoma K, Fujikawa M, et al. Fibrosis in Preeclamptic

placentas is associated with stromal fibroblasts activated by the

transforming growth factor-β1 signaling pathway. Am J Pathol. 2018;188:

683–95.

32. Asanoma K, Liu G, Yamane T, et al. Regulation of the mechanism of TWIST1

transcription by BHLHE40 and BHLHE41 in Cancer cells. Mol Cell Biol. 2015;

35:4096–109.

33. Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer.

2016;16:582–98.

34. Shi Q, Bao S, Maxwell JA, et al. Secreted protein acidic, rich in cysteine

(SPARC), mediates cellular survival of gliomas through AKT activation. J Biol

Chem. 2004;279:52200–9.

35. Shi Q, Bao S, Song L, et al. Targeting SPARC expression decreases glioma

cellular survival and invasion associated with reduced activities of FAK and

ILK kinases. Oncogene. 2007;26:4084–94.

36. Koukourakis MI, Giatromanolaki A, Brekken RA, et al. Enhanced expression of

SPARC/osteonectin in the tumor-associated stroma of non-small cell lung

cancer is correlated with markers of hypoxia/acidity and with poor

prognosis of patients. Cancer Res. 2003;63:5376–80.

37. Mantoni TS, Schendel RR, Rodel F, et al. Stromal SPARC expression and

patient survival after chemoradiation for non-resectable pancreatic

adenocarcinoma. Cancer Biol Ther. 2008;7:1806–15.

38. Chlenski A, Liu S, Guerrero LJ, et al. SPARC expression is associated with

impaired tumor growth, inhibited angiogenesis and changes in the

extracellular matrix. Int J Cancer. 2006;118:310–6.

Yoshida et al. BMC Cancer

(2021) 21:156

39. Sangaletti S, Tripodo C, Santangelo A, et al. Mesenchymal transition of highgrade breast carcinomas depends on extracellular matrix control of myeloid

suppressor cell activity. Cell Rep. 2016;17:233–48.

40. Zhu J, Wang LY, Li CY, et al. SPARC promotes self-renewal of limbal

epithelial stem cells and ocular surface restoration through JNK and p38MAPK signaling pathways. Stem Cells. 2020;38:134–45.

41. Sharma S, Xing F, Liu Y, et al. Secreted protein acidic and rich in cysteine

(SPARC) mediates metastatic dormancy of prostate Cancer in bone. J Biol

Chem. 2016;291:19351–63.

42. Salzer MC, Lafzi A, Berenguer-Llergo A et al. Identity Noise and Adipogenic

Traits Characterize Dermal Fibroblast Aging. Cell. 2018; 175: 1575–1590.

e1522.

43. Neumann E, Riepl B, Knedla A, et al. Cell culture and passaging alters gene

expression pattern and proliferation rate in rheumatoid arthritis synovial

fibroblasts. Arthritis Res Ther. 2010;12:R83.

44. Dawson K, Wu CT, Qi XY, et al. Congestive heart failure effects on atrial

fibroblast phenotype: differences between freshly-isolated and cultured

cells. PLoS One. 2012;7:e52032.

45. Bauer M, Su G, Casper C, et al. Heterogeneity of gene expression in stromal

fibroblasts of human breast carcinomas and normal breast. Oncogene. 2010;

29:1732–40.

46. Kooistra A, Elissen NM, König JJ, et al. Immunocytochemical characterization

of explant cultures of human prostatic stromal cells. Prostate. 1995;27:42–9.

47. Kusunoki S, Kato K, Tabu K, et al. The inhibitory effect of salinomycin on the

proliferation, migration and invasion of human endometrial cancer stem-like

cells. Gynecol Oncol. 2013;129:598–605.

48. Barker TH, Baneyx G, Cardo-Vila M, et al. SPARC regulates extracellular matrix

organization through its modulation of integrin-linked kinase activity. J Biol

Chem. 2005;280:36483–93.

49. Golembieski WA, Thomas SL, Schultz CR, et al. HSP27 mediates SPARCinduced changes in glioma morphology, migration, and invasion. Glia. 2008;

56:1061–75.

50. Alam R, Schultz CR, Golembieski WA, et al. PTEN suppresses SPARC-induced

pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in

glioma. Neuro-Oncology. 2013;15:451–61.

51. Nagaraju GP, Sharma D. Anti-cancer role of SPARC, an inhibitor of

adipogenesis. Cancer Treat Rev. 2011;37:559–66.

52. Murphy-Ullrich JE. The de-adhesive activity of matricellular proteins: is

intermediate cell adhesion an adaptive state? J Clin Invest. 2001;107:785–90.

53. Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression

by enhancing integrin signaling. Cell. 2009;139:891–906.

54. Ng MR, Brugge JS. A stiff blow from the stroma: collagen crosslinking drives

tumor progression. Cancer Cell. 2009;16:455–7.

55. Girotti MR, Fernandez M, Lopez JA, et al. SPARC promotes cathepsin Bmediated melanoma invasiveness through a collagen I/alpha2beta1 integrin

axis. J Invest Dermatol. 2011;131:2438–47.

56. Nakamura K, Yamanouchi K, Nishihara M. Secreted protein acidic and rich in

cysteine internalization and its age-related alterations in skeletal muscle

progenitor cells. Aging Cell. 2014;13:175–84.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in

published maps and institutional affiliations.

Page 12 of 12

...